REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 8th, 2021 • Jaguar Health, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 8th, 2021 Company Industry JurisdictionREGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of April 7, 2021 (the “Execution Date”), is entered into by and between JAGUAR HEALTH, INC., a Delaware corporation (the “Company”), and OASIS CAPITAL, LLC, a Puerto Rico limited liability company (together with its permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in that certain First Amendment to the Equity Purchase Agreement by and between the parties hereto, dated as of the Execution Date (as amended, restated, supplemented or otherwise modified from time to time, the “Amendment”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 9th, 2019 • Premier Biomedical Inc • Biological products, (no disgnostic substances) • Nevada
Contract Type FiledOctober 9th, 2019 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 26, 2019 (the “Execution Date”), is entered into by and between PREMIER BIOMEDICAL, INC., a Nevada corporation (the “Company”), and GREEN COAST CAPITAL INTERNATIONAL SA, a Panama Corporation (together with its permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in that certain Equity Purchase Agreement by and between the parties hereto, dated as of the Execution Date (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 4th, 2019 • MGT Capital Investments, Inc. • Patent owners & lessors • Kansas
Contract Type FiledJune 4th, 2019 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 3, 2019 (the “Execution Date”), is entered into by and between MGT CAPITAL INVESTMENTS, INC., a Delaware corporation (the “Company”), and OASIS CAPITAL, LLC, a Puerto Rico limited liability company (together with its permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in that certain Equity Purchase Agreement by and between the parties hereto, dated as of the Execution Date (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 25th, 2019 • Propanc Biopharma, Inc. • Pharmaceutical preparations • Kansas
Contract Type FiledFebruary 25th, 2019 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of February 25, 2019 (the “Execution Date”), is entered into by and between PROPANC BIOPHARMA, INC., a Delaware corporation (the “Company”), and OASIS CAPITAL, LLC, a Puerto Rico limited liability company (together with its permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in that certain Equity Purchase Agreement by and between the parties hereto, dated as of the Execution Date (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).